Hannah Valantine - Director at BridgeBio Pharma, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- BBIO on Nasdaq
- All Insider Reports
- All Insider Reports
Hannah Valantine - trading volume in the past year for BridgeBio Pharma, Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -68,638 | 100% | $64.17 | -$4,404,828 |
| Net | -68,638 | -100% | -$4,404,828 |
Holdings reported by Hannah Valantine for BridgeBio Pharma, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 7,465 | $537,480 | $72.00 | 10 Mar 2026 | Direct | ||
| Common Stock | 398 | $27,083 | $68.05 | 10 Mar 2026 | By Spouse | ||
| Stock Option (Right to Buy) | 17,343 | 10 Mar 2026 | Direct | Common Stock |
Transactions reported by Hannah Valantine for BridgeBio Pharma, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.